These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 2242781)

  • 41. Different sensitivities to ultraviolet light-induced cytotoxicity and sister chromatid exchanges in xeroderma pigmentosum and Bloom's syndrome fibroblasts.
    Mamada A; Kondo S; Satoh Y
    Photodermatol; 1989 Jun; 6(3):124-30. PubMed ID: 2762203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
    Tofuku Y; Nobeyama Y; Kamide R; Moriwaki S; Nakagawa H
    J Dermatol; 2015 Sep; 42(9):897-9. PubMed ID: 26010807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
    Kondo S; Satoh Y; Kuroki T
    Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Multiple melanoma in xeroderma pigmentosum].
    Fölster-Holst R; Schubert C; Christophers E
    Hautarzt; 1994 Aug; 45(8):554-61. PubMed ID: 7960757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiloculated lentigo maligna melanoma in a patient without evidence for xeroderma pigmentosum.
    Brandt O; Abeck D; Weichenthal M; Steinkraus V; Breitbart E; Jung EG; Ring J
    Acta Derm Venereol; 1995 Jul; 75(4):326-7. PubMed ID: 8578964
    [No Abstract]   [Full Text] [Related]  

  • 47. Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype.
    Itoh T; Cleaver JE; Yamaizumi M
    Hum Genet; 1996 Feb; 97(2):176-9. PubMed ID: 8566949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
    Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
    Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defect in UV-induced unscheduled DNA synthesis in cultured epidermal keratinocytes from xeroderma pigmentosum.
    Kondo S; Satoh Y; Kuroki T
    Mutat Res; 1987 Jan; 183(1):95-101. PubMed ID: 2432425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Erythema action spectrum in xeroderma pigmentosum group A patients].
    Mitoh Y
    Nihon Hifuka Gakkai Zasshi; 1989 Jan; 99(1):9-14. PubMed ID: 2746965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal leiomyosarcoma associated with xeroderma pigmentosum.
    Tomás M; Salinas AS; Moreno J; Server G
    Arch Esp Urol; 1989 Jun; 42(5):484-6. PubMed ID: 2817979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assignment of 2 patients with xeroderma pigmentosum to complementation group E.
    Fujiwara Y; Uehara Y; Ichihashi M; Yamamoto Y; Nishioka K
    Mutat Res; 1985; 145(1-2):55-61. PubMed ID: 3974603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interspecies complementation analysis of xeroderma pigmentosum and UV-sensitive Chinese hamster cells.
    Stefanini M; Keijzer W; Westerveld A; Bootsma D
    Exp Cell Res; 1985 Dec; 161(2):373-80. PubMed ID: 4065224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xeroderma pigmentosum complementation group F in a non-Japanese patient.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1185-8. PubMed ID: 3372781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
    Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
    Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
    Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xeroderma pigmentosum. Complementation group C and malignant melanoma.
    Lynch HT; Fusaro RM; Johnson JA
    Arch Dermatol; 1984 Feb; 120(2):175-9. PubMed ID: 6696469
    [No Abstract]   [Full Text] [Related]  

  • 59. Repair of UV-endonuclease-susceptible sites in the 7 complementation groups of xeroderma pigmentosum A through G.
    Zelle B; Lohman PH
    Mutat Res; 1979 Sep; 62(2):363-8. PubMed ID: 503100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microinjection of partially purified protein factor restores DNA damage specifically in group A of xeroderma pigmentosum cells.
    Yamaizumi M; Sugano T; Asahina H; Okada Y; Uchida T
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1476-9. PubMed ID: 3456596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.